"Leishmaniasis, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Descriptor ID |
D016773
|
| MeSH Number(s) |
C03.752.300.500.400 C03.858.560.400 C17.800.838.775.560.400
|
| Concept/Terms |
Oriental Sore- Oriental Sore
- Sore, Oriental
- Leishmaniasis, Old World
- Old World Leishmaniasis
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis, Cutaneous".
This graph shows the total number of publications written about "Leishmaniasis, Cutaneous" by people in this website by year, and whether "Leishmaniasis, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 1 | 4 |
| 2017 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmaniasis, Cutaneous" by people in Profiles.
-
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis. Protein Expr Purif. 2021 01; 177:105750.
-
Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa. PLoS Negl Trop Dis. 2016 05; 10(5):e0004545.
-
Status of vaccine research and development of vaccines for leishmaniasis. Vaccine. 2016 06 03; 34(26):2992-2995.
-
Cutaneous leishmaniasis in Cuban immigrants to Texas who traveled through the Dari?n Jungle, Panama. Am J Trop Med Hyg. 2014 Aug; 91(2):345-7.
-
Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility. J Immunol. 2007 Aug 15; 179(4):2435-44.
-
Differential requirement for CD18 in T-helper effector homing. Nat Med. 2003 Oct; 9(10):1281-6.
-
Epidemiology of cutaneous leishmaniasis in Colombia: environmental and behavioral risk factors for infection, clinical manifestations, and pathogenicity. J Infect Dis. 1993 Sep; 168(3):709-14.
-
Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations. J Infect Dis. 1993 Sep; 168(3):699-708.
-
A clinical prediction rule for American cutaneous leishmaniasis in Colombia. Int J Epidemiol. 1993 Jun; 22(3):548-58.